Oliver Germershaus is Professor for Pharmaceutical Technology of Macromolecular Drugs at the University of Applied Sciences and Arts Northwestern Switzerland (FHNW) , where he serves as Head of Institute for Pharma Technology and Biotechnology . He holds a School of Life Sciences affiliation and licenses as a pharmacist in Germany. Academic background includes: PhD in Pharmaceutical Sciences (University of Marburg, 2007) MSc in Pharmacy (University of Halle-Wittenberg, 2003) University of Marburg education (2002) Research focuses on drug delivery systems for large molecules including peptides, proteins, and nucleic acids. His work spans biopharmaceutical formulation development , excipient interaction analysis , and packaging compatibility studies . Key methodologies include white light interferometry for medical device characterization, self-assembling peptide hydrogels for localized drug delivery, and MMP-responsive systems for bioactive material design. Recent publications demonstrate expertise in: Standard particle fabrication via micro 3D printing (2024) PS20 surfactant degradation patterns in mAb formulations (2024) Alternative surfactant selection for biopharmaceuticals (2023) Silk fibroin modification for implant applications (2018) Medical device lubrication analysis (2018) Matrix metalloprotease responsive systems (2018) Professional memberships include: Swiss Academy of Pharmaceutical Sciences (SAPhW) Controlled Release Society (CRS) Germany Chapter Swiss Society of Industrial Pharmacists (GSIA) Parenteral Drug Association (PDA) American Chemical Society (ACS) Academic leadership roles: Co-Organizer PharmaLunch Basel Editorial Board, Asian Journal of Pharmaceutical Sciences Reviewer for German Research Foundation and 10+ journals






